ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA)
CUSIP: 488445206
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 56,066,823
- Total 13F shares
- 36,165,830
- Share change
- +880,264
- Total reported value
- $318,624,169
- Put/Call ratio
- 161%
- Price per share
- $8.81
- Number of holders
- 119
- Value change
- +$9,847,978
- Number of buys
- 67
- Number of sells
- 43
Quarterly Holders Quick Answers
What is CUSIP 488445206?
CUSIP 488445206 identifies ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 488445206:
Top shareholders of ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Woodline Partners LP |
13F
|
Company |
8.2%
|
4,615,625
|
$34,571,031 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.6%
from 13D/G
|
4,126,563
|
$30,907,956 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
6.5%
|
3,618,000
|
$27,098,820 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5%
|
2,825,845
|
$21,165,578 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
4.1%
|
2,306,317
|
$17,274,313 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13D/G
13F
|
Company |
4.4%
|
2,340,333
|
$16,920,608 | -$4,220,064 | 31 Dec 2024 | |
| Samuel J. Braun |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,153,000
|
$15,636,043 | — | 13 May 2021 | |
| AIGH Capital Management LLC |
13F
|
Company |
2.6%
|
1,438,109
|
$10,771,437 | — | 31 Mar 2025 | |
| Altium Capital Management LLC |
13F
|
Company |
2.3%
|
1,287,333
|
$9,642,124 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
1,233,111
|
$9,238,375 | — | 31 Mar 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
2.2%
|
1,225,834
|
$9,181,497 | — | 31 Mar 2025 | |
| Rubric Capital Management LP |
13F
|
Company |
2.2%
|
1,217,734
|
$9,120,828 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
1,176,548
|
$8,812,345 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.2%
|
114,934
|
$6,650,237 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
1.3%
|
737,737
|
$5,518,982 | — | 31 Mar 2025 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
1.2%
|
683,032
|
$5,115,910 | — | 31 Mar 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
1.2%
|
665,000
|
$4,980,850 | — | 31 Mar 2025 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
1.2%
|
650,000
|
$4,868,500 | — | 31 Mar 2025 | |
| Retirement Planning Co of New England, Inc. |
13F
|
Company |
0.98%
|
550,180
|
$4,120,848 | — | 31 Mar 2025 | |
| J. Goldman & Co LP |
13F
|
Company |
0.87%
|
489,647
|
$3,667,456 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.78%
|
434,690
|
$3,255,829 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.77%
|
429,111
|
$3,214,042 | — | 31 Mar 2025 | |
| Mystic Asset Management, Inc. |
13F
|
Company |
0.6%
|
338,902
|
$2,538,376 | — | 31 Mar 2025 | |
| Stratos Wealth Partners, LTD. |
13F
|
Company |
0.55%
|
310,000
|
$2,321,900 | — | 31 Mar 2025 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.5%
|
280,534
|
$2,101,000 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.44%
|
248,832
|
$1,863,752 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.38%
|
211,848
|
$1,586,742 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.35%
|
194,813
|
$1,459,149 | — | 31 Mar 2025 | |
| Propel Bio Management, LLC |
13F
|
Company |
0.32%
|
179,874
|
$1,347,256 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.3%
|
165,415
|
$1,238,958 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.29%
|
163,064
|
$1,221,349 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.27%
|
153,331
|
$1,148,449 | — | 31 Mar 2025 | |
| Kovack Advisors, Inc. |
13F
|
Company |
0.26%
|
146,747
|
$1,099,133 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.25%
|
140,418
|
$1,051,731 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.21%
|
120,433
|
$902,040 | — | 31 Mar 2025 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.21%
|
120,000
|
$898,800 | — | 31 Mar 2025 | |
| Travis C. Mickle |
3/4/5
|
President & CEO, Director |
—
class O/S missing
|
171,774
|
$851,845 | — | 25 May 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.19%
|
108,701
|
$814,170 | — | 31 Mar 2025 | |
| CREDIT AGRICOLE S A |
13F
|
Individual |
0.19%
|
106,000
|
$793,940 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.16%
|
89,415
|
$669,718 | — | 31 Mar 2025 | |
| Arete Wealth Advisors, LLC |
13F
|
Company |
0.13%
|
74,854
|
$561,000 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.13%
|
74,585
|
$558,630 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.12%
|
68,050
|
$509,695 | — | 31 Mar 2025 | |
| Sven Guenther |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
79,000
|
$391,769 | — | 31 Jan 2024 | |
| Christal M. M. Mickle |
3/4/5
|
Chief Development Officer |
—
class O/S missing
|
77,000
|
$381,851 | — | 31 Jan 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.08%
|
45,681
|
$342,151 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.08%
|
44,121
|
$330,465 | — | 31 Mar 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.07%
|
41,932
|
$314,000 | — | 31 Mar 2025 | |
| EntryPoint Capital, LLC |
13F
|
Company |
0.07%
|
40,675
|
$304,656 | — | 31 Mar 2025 | |
| CARRET ASSET MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
36,140
|
$270,689 | — | 31 Mar 2025 |
Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) as of Q2 2025
As of 30 Jun 2025,
ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,165,830 shares.
The largest 10 holders included
Woodline Partners LP, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc., VANGUARD GROUP INC, FMR LLC, Rubric Capital Management LP, Nantahala Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and 683 Capital Management, LLC.
This page lists
120
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
109
Q2 2025 holders
119
Holder diff
10
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.